GENITOURINARY CANCERS

Latest News

CheckMate 274 Confirms Benefit of Nivolumab for Bladder Cancer
CheckMate 274 Confirms Benefit of Nivolumab for Bladder Cancer

April 15th 2025

During a live event, Matthew Galsky, MD, discussed adjuvant nivolumab in muscle-invasive bladder cancer and the benefit in patients with high PD-L1.

Nivolumab Plus Ipilimumab Trends Toward Prolonged OS in nccRCC
Nivolumab Plus Ipilimumab Trends Toward Prolonged OS in nccRCC

April 15th 2025

FDA to Review Nogapendekin Alfa in Bladder Cancer and Lymphopenia
FDA to Review Nogapendekin Alfa in Bladder Cancer and Lymphopenia

April 15th 2025

Exploring Neoadjuvant and Adjuvant Therapies for Patients With MIBC
Exploring Neoadjuvant and Adjuvant Therapies for Patients With MIBC

April 11th 2025

FDA Greenlights Bevacizumab Biosimilar Across Cancer Types
FDA Greenlights Bevacizumab Biosimilar Across Cancer Types

April 10th 2025

More News